Technology

Unity Biotechnology

$6.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.29%) Today
-$0.01 (-0.15%) As of 11:39 AM UTC after-hours

Why Robinhood?

You can buy or sell UBX and other stocks, options, and ETFs commission-free!

About UBX

Unity Biotechnology, Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi and Daohong Zhou on March 30, 2009 and is headquartered in Brisbane, CA. The listed name for UBX is Unity Biotechnology, Inc. Common Stock.

CEO
Anirvan Ghosh
Employees
98
Headquarters
Brisbane, California
Founded
2009
Market Cap
354.01M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.06M
High Today
$6.86
Low Today
$6.60
Open Price
$6.82
Volume
608.74K
52 Week High
$15.44
52 Week Low
$2.72

Collections

UBX Earnings

-$0.59
-$0.39
-$0.20
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 10, After Hours

You May Also Like

LTRN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure